Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 315
7
Diseases
11
Unique genes
0.246
Avg. similarity score
Deafness, autosomal dominant, 75
Most-connected disease (5 links)
Disease
Searched: Taurodontism, microdontia, and dens invaginatus
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Taurodontism, microdontia, and dens invaginatus
Deafness, autosomal dominant, 75
Developmental delay with or without dysmorphic facies and autism
Developmental delay with or without intellectual or behavioral abnormalities
Complex neurodevelopmental disorder with or without congenital anomalies
Abnormal heart morphology
Abnormality of the urinary system
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Deafness, autosomal dominant, 75 | 5 | 5 | 1 |
| Developmental delay with or without dysmorphic facies and autism | 5 | 5 | 1 |
| Developmental delay with or without intellectual or behavioral abnormalities | 5 | 5 | 2 |
| Complex neurodevelopmental disorder with or without congenital anomalies | 4 | 4 | 5 |
| Abnormal heart morphology | 3 | 3 | 5 |
| Abnormality of the urinary system | 3 | 3 | 2 |
| Taurodontism, microdontia, and dens invaginatus | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TRRAP | 6 / 7 | Abnormal heart morphology, Abnormality of the urinary system, Complex neurodevelopmental disorder with or without congenital anomalies, Deafness, autosomal dominant, 75 and 2 more |
| KIF4A | 2 / 7 | Complex neurodevelopmental disorder with or without congenital anomalies, Taurodontism, microdontia, and dens invaginatus |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interactions of Tat with host cellular proteins | Reactome | 1 / 2 | 546× | 1.83e-3 | 1.78e-2 ✓ sig. |
| Resolution of Sister Chromatid Cohesion | Reactome | 2 / 126 | 17.3× | 5.65e-3 | 3.96e-2 ✓ sig. |
| Estrogen-dependent gene expression | Reactome | 2 / 150 | 14.6× | 7.92e-3 | 4.93e-2 ✓ sig. |
| Cohesin Loading onto Chromatin | Reactome | 1 / 10 | 109× | 9.12e-3 | 5.37e-2 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | Reactome | 1 / 10 | 109× | 9.12e-3 | 5.37e-2 |
| Establishment of Sister Chromatid Cohesion | Reactome | 1 / 11 | 99.3× | 1.00e-2 | 5.69e-2 |
| Separation of Sister Chromatids | Reactome | 2 / 190 | 11.5× | 1.25e-2 | 6.50e-2 |
| Motor proteins | KEGG | 2 / 194 | 11.3× | 1.30e-2 | 6.64e-2 |
| Sema3A PAK dependent Axon repulsion | Reactome | 1 / 15 | 72.8× | 1.37e-2 | 6.87e-2 |
| CRMPs in Sema3A signaling | Reactome | 1 / 16 | 68.2× | 1.46e-2 | 7.13e-2 |
| Virion - Lassa virus and SFTS virus | KEGG | 1 / 17 | 64.2× | 1.55e-2 | 7.39e-2 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | Reactome | 1 / 23 | 47.5× | 2.09e-2 | 8.78e-2 |
| RHO GTPases activate PAKs | Reactome | 1 / 23 | 47.5× | 2.09e-2 | 8.78e-2 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | Reactome | 1 / 32 | 34.1× | 2.89e-2 | 1.06e-1 |
| Recycling pathway of L1 | Reactome | 1 / 40 | 27.3× | 3.60e-2 | 1.20e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| negative regulation of transcription regulatory region DNA binding | GO:2000678 | 1 / 1 | 1,699× | 5.89e-4 | 1.06e-2 ✓ sig. |
| regulation of DNA repair | GO:0006282 | 2 / 63 | 53.9× | 6.03e-4 | 1.08e-2 ✓ sig. |
| mitotic cytokinesis | GO:0000281 | 2 / 68 | 50.0× | 7.03e-4 | 1.19e-2 ✓ sig. |
| closure of optic fissure | GO:0061386 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| cerebellar Purkinje cell layer maturation | GO:0021691 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| positive regulation of lens epithelial cell proliferation | GO:2001111 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| fourth ventricle development | GO:0021592 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| cerebellar granule cell precursor tangential migration | GO:0021935 | 1 / 2 | 849× | 1.18e-3 | 1.59e-2 ✓ sig. |
| radial glia guided migration of Purkinje cell | GO:0021942 | 1 / 3 | 566× | 1.76e-3 | 1.99e-2 ✓ sig. |
| pyramidal neuron migration to cerebral cortex | GO:0021852 | 1 / 3 | 566× | 1.76e-3 | 1.99e-2 ✓ sig. |
| positive regulation of protein localization to chromatin | GO:0120187 | 1 / 3 | 566× | 1.76e-3 | 1.99e-2 ✓ sig. |
| spindle elongation | GO:0051231 | 1 / 3 | 566× | 1.76e-3 | 1.99e-2 ✓ sig. |
| regulation of mRNA 3'-end processing | GO:0031440 | 1 / 4 | 425× | 2.35e-3 | 2.30e-2 ✓ sig. |
| vitellogenesis | GO:0007296 | 1 / 4 | 425× | 2.35e-3 | 2.30e-2 ✓ sig. |
| soft palate development | GO:0060023 | 1 / 5 | 340× | 2.94e-3 | 2.58e-2 ✓ sig. |